文献速递神经肿瘤

肾素-血管紧张素系统在胶质瘤生物标志物与治疗中的作用

Renin angiotensin system and its role in biomarkers and treatment in gliomas.
PubMed 文献 · J Neurooncol · 2018-02-16

本文综述肾素-血管紧张素系统(RAS)在胶质瘤发生中的作用。RAS肽段及受体在胶质瘤等肿瘤中表达,其失调参与增殖、血管生成和侵袭。RAS肽段与受体有望作为生物标志物,RAS阻断剂在胶质瘤中显示出广泛有益效应,正被考虑用于治疗方案。

要点

  • 高级别胶质瘤手术加辅助治疗后平均总生存15个月,复发率100%。
  • RAS肽段和受体在胶质瘤等肿瘤中表达,其失调参与增殖、血管生成和侵袭。
  • RAS阻断剂在胶质瘤中显示出广泛有益效应,正被考虑用于治疗方案。

核心结论

  • RAS肽段与受体作为胶质瘤生物标志物可能带来优势,未来应考虑应用。
  • RAS阻断剂在胶质瘤中显示出广泛有益效应,正被考虑用于治疗方案。

研究设计与样本

  • 本文为综述,旨在总结RAS在胶质瘤发生中作用的背景,并探讨其作为生物标志物和治疗辅助手段的证据。

主要发现

  • 高级别胶质瘤患者接受手术切除加辅助治疗的平均总生存为15个月,复发率100%。
  • RAS肽段和受体的表达已在包括胶质瘤在内的不同种类肿瘤中检测到。
  • RAS成分失调在肿瘤的增殖、血管生成和侵袭中起重要作用,并因此影响结局。

临床怎么用

  • RAS肽段与受体作为胶质瘤生物标志物的研究及潜在应用可能带来优势,未来应考虑。
  • RAS阻断剂在胶质瘤中显示出广泛有益效应,正被考虑用于治疗方案。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Gliomas are the most common primary intrinsic tumor in the brain and are classified as low- or high-grade according to the World Health Organization (WHO). Patients with high-grade gliomas (HGG) who undergo surgical resection with adjuvant therapy have a mean overall survival of 15 months and 100% recurrence. The renin-angiotensin system (RAS), the primary regulator of cardiovascular circulation, exhibits local action and works as a paracrine system. In the context of this local regulation, the expression of RAS peptides and receptors has been detected in different kinds of tumors, including gliomas. The dysregulation of RAS components plays a significant role in the proliferation, angiogenesis, and invasion of these tumors, and therefore in their outcomes. The study and potential application of RAS peptides and receptors as biomarkers in gliomas could bring advantages against the limitations of current tumoral markers and should be considered in the future. The targeting of RAS components by RAS blockers has shown potential of being protective against cancer and improving immunotherapy. In gliomas, RAS blockers have shown a broad spectrum for beneficial effects and are being considered for use in treatment protocols. This review aims to summarize the background behind how RAS plays a role in gliomagenesis and explore the evidence that could lead to their use as biomarkers and treatment adjuvants.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Perdomo-Pantoja A, Mejía-Pérez SI, Gómez-Flores-Ramos L, et al. Renin angiotensin system and its role in biomarkers and treatment in gliomas. J Neurooncol. 2018. PMID: 29450812. doi:10.1007/s11060-018-2789-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。